CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER Drug Patent Profile
✉ Email this page to a colleague
When do Clindamycin Phosphate In 5% Dextrose In Plastic Container patents expire, and what generic alternatives are available?
Clindamycin Phosphate In 5% Dextrose In Plastic Container is a drug marketed by Baxter Hlthcare Corp, Rising, and Sandoz Inc. and is included in three NDAs.
The generic ingredient in CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER is clindamycin phosphate. There are fifty-five drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the clindamycin phosphate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Clindamycin Phosphate In 5% Dextrose In Plastic Container
A generic version of CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER was approved as clindamycin phosphate by ALMAJECT on July 24th, 1987.
Summary for CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER
| US Patents: | 0 |
| Applicants: | 3 |
| NDAs: | 3 |
| Finished Product Suppliers / Packagers: | 3 |
| Clinical Trials: | 30 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER at DailyMed |
Recent Clinical Trials for CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Daré Bioscience, Inc. | Phase 1 |
| Memorial Sloan Kettering Cancer Center | Phase 2 |
| Daré Bioscience, Inc. | Phase 3 |
See all CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER clinical trials
Pharmacology for CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER
| Drug Class | Lincosamide Antibacterial |
| Physiological Effect | Decreased Sebaceous Gland Activity Neuromuscular Blockade |
Anatomical Therapeutic Chemical (ATC) Classes for CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER
US Patents and Regulatory Information for CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baxter Hlthcare Corp | CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER | clindamycin phosphate | INJECTABLE;INJECTION | 208084-001 | Jun 28, 2017 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Sandoz Inc | CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER | clindamycin phosphate | INJECTABLE;INJECTION | 201692-001 | May 31, 2012 | AP | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Rising | CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER | clindamycin phosphate | INJECTABLE;INJECTION | 203048-001 | Apr 4, 2013 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Sandoz Inc | CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER | clindamycin phosphate | INJECTABLE;INJECTION | 201692-002 | May 31, 2012 | AP | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
